GCG and type 1 diabetes mellitus: Although acute administration of glucagon to hypoglycemic type 1 diabetes patients is an effective treatment to stimulate endogenous glucose production, its role in the endogenous CRR in type 1 diabetes is limited due to pancreatic alpha- and beta-cell failure.